A recent study published in Cancer highlights that younger women with breast cancer often face delays in diagnosis and treatment. The research, involving 1,071 women diagnosed before age 40, found that lower income and younger age were linked to these delays. Specifically, the analysis revealed that women experiencing delays in cancer diagnoses were more likely to have later-stage disease, showing the critical impact of timely care.
Tracking delays from symptoms to treatment
The study identified 153 presentation delays, 120 diagnostic delays, and 228 treatment delays. Presentation delays were defined as 90 days or more from first symptoms to seeing a clinician, diagnostic delays as 90 days or more from the first healthcare visit to biopsy, and treatment delays as 60 days or more from diagnosis to first treatment. These delays were measured using data from the Young Women’s Breast Cancer Study, a multisite prospective cohort, ensuring robust and detailed insights into the timing of care.
Lower income increased the odds of presentation delays, while pregnancy at diagnosis, family history of breast cancer, and triple-negative breast cancer reduced these odds. Presentation delays were also associated with later-stage disease in women with certain HER2-positive tumors. Younger patients faced higher odds of diagnostic delays, but those with triple-negative tumors had lower odds. Treatment delays were less likely for patients with aggressive tumor types, suggesting that urgency in care increases with tumor severity.
Income and age linked to delays
Breast cancer before 40 often carries a poor prognosis and unique challenges. Younger women typically don’t undergo screening and may delay addressing symptoms due to assumptions about their age. This study, detailed in Cancer (DOI: 10.1002/cncr.70594), shows the importance of addressing these gaps in care. The findings were also reported in Medical Xpress on October 12, 2026, highlighting the broader implications for healthcare systems and patient education.